Effect of PrP105‑132 on the secretion of interleukin‑6 and interleukin‑8 from microglial cells in vitro

Yang,Yun‑Tian; Jin,Shan

doi:10.3892/etm.2017.5498

Effect of PrP105‑132 on the secretion of interleukin‑6 and interleukin‑8 from microglial cells in vitro

Authors:
- Yun‑Tian Yang
- Shan Jin
View Affiliations

Affiliations: Department of Neurology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, P.R. China, Department of General Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 010050, P.R. China
Published online on: November 13, 2017 https://doi.org/10.3892/etm.2017.5498
Pages: 999-1004

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, the effect of prion protein (PrP) on the secretion of interleukin‑6 (IL‑6) and IL‑8 from microglial cells in vitro and its possible underlying pathway were investigating by establishing a cell model for prion disease. Rat neuroglial cells were cultured in vitro, and were treated with 80 µM PrP peptides 105‑132 (PrP105‑132) only, PrP+MG132 or PrP+cyclosporin A (CsA). After 48 h, the IL‑6 and IL‑8 levels in the supernatant fluid of the treated cells were detected using enzyme‑linked immunosorbent assay. In addition, the expression levels of nuclear factor‑κB (NF‑κB) and nuclear factor of activated T cells (NFAT) were evaluated using reverse transcription‑polymerase chain reaction. The results indicated that the microglial cells were activated by treatment with PrP peptides. Cell bodies were augmented and appeared to have round, rod and amoeba‑like shapes. In addition, the protuberances were shortened and eventually disappeared. Furthermore, the mRNA expression levels of NF‑κB and NFAT in microglial cells increased, as well as the IL‑6 and IL‑8 levels in the supernatant fluid after treatment with PrP. However, the mRNA expression levels of NF‑κB, and the IL‑6 and IL‑8 levels decreased after these cells were treated with MG132, a specific inhibitor of NF‑κB. The mRNA expression of NFAT decreased after these cells were treated with CsA, a specific inhibitor of NFAT; however, the IL‑6 level decreased, while no significant difference was observed in the IL‑8 level. In conclusion, PrP‑treated microglial cells secreted IL‑6 and IL‑8, and the secretion of IL‑6 was associated with the activation of NF‑κB and NFAT pathways. In addition, the secretion of IL‑8 was mainly dependent on the NF‑κB pathway.

View Figures

View References

1	Bastian FO, Sanders DE, Forbes WA, Hagius SD, Walker JV, Henk WG, Enright FM and Elzer PH: Spiroplasma spp. from transmissible spongiform encephalopathy brains or ticks induce spongiform encephalopathy in ruminants. J Med Microbiol. 56:1235–1242. 2007. View Article : Google Scholar : PubMed/NCBI
2	Iwasaki Y, Iijima M, Kimura S, Yoshida M, Hashizume Y, Yamada M, Kitamoto T and Sobue G: Autopsy case of sporadic Creutzfeldt-Jakob disease presenting with signs suggestive of brainstem and spinal cord involvement. Neuropathology. 26:550–556. 2006. View Article : Google Scholar : PubMed/NCBI
3	Prusiner SB: Prions. Proc Natl Acad Sci USA. 95:pp. 13363–13383. 1998; View Article : Google Scholar : PubMed/NCBI
4	Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM and Collinge J: Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science. 300:640–643. 2003. View Article : Google Scholar : PubMed/NCBI
5	Iwata K, Chiang CY and Cherkas P: Glial cells in orofacial pathological pain mechanismsEncyclopedia of Pain. Schmidt RF and Gebhart GF: 10. 2nd. Springer; Berlin: pp. 1374–1378. 2013, View Article : Google Scholar
6	Zindler E and Zipp F: Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol. 24:551–562. 2010. View Article : Google Scholar : PubMed/NCBI
7	Nakamichi K, Kitani H, Takayama-Ito M, Morimoto K, Kurane I and Saijo M: Celastrol suppresses morphological and transcriptional responses in microglial cells upon stimulation with double-stranded RNA. Int J Neurosci. 120:252–257. 2010. View Article : Google Scholar : PubMed/NCBI
8	Yang YT, Jiang XM and Lin SH: The change of cytokine IL-6 in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Zhong Guo Hao Nian Xue Za Zhi. 29:187–188. 2009.(In Chinese).
9	Yang YT, Jiang XM and Lin SH: The change of cytokine IL-8 in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Zhong Guo Ren Shou Gong Huan Bing Xue Bao. 25:1083–1084. 2009.(In Chinese).
10	Moresco RM, Messa C, Tagliavini F, Panzacchi A, Giovagnoli MR, Matarrese M, Pietra L, Bertoldo A, Rizzo G, Giaccone G, et al: Creutzfeldt-Jakob disease: Activated microglia detected in vivo by molecular imaging. Neuropathol Appl Neurobiol. 30:415–416. 2004.
11	Peyrin JM, Lasmézas CI, Haïk S, Tagliavini F, Salmona M, Williams A, Richie D, Deslys JP and Dormont D: Microglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines. NeuroReport. 10:723–729. 1999. View Article : Google Scholar : PubMed/NCBI
12	Yang YT and Fu Q: Effect of PrP105-132 on secretion of IL-8 from microglial cells in vitro. Zhong Guo Ren Shou Gong Huan Bing Xue Bao. 31:1046–1049. 2015.(In Chinese).
13	Raibaut L, Mahdi OE and Melnyk O: Solid phase protein chemical synthesis. Top Curr Chem. 363:103–154. 2015. View Article : Google Scholar : PubMed/NCBI
14	Giulian D and Baker TJ: Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci. 6:2163–2178. 1986.PubMed/NCBI
15	Tatzelt J and Schätzl HM: Molecular basis of cerebral neurodegeneration in prion diseases. FEBS J. 274:606–611. 2007. View Article : Google Scholar : PubMed/NCBI
16	Williams AE, van Dam AM, Man-A-Hing WK, Berkenbosch F, Eikelenboom P and Fraser H: Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice. Brain Res. 654:200–206. 1994. View Article : Google Scholar : PubMed/NCBI
17	Dheen ST, Kaur C and Ling EA: Microglial activation and its implications in the brain diseases. Curr Med Chem. 14:1189–1197. 2007. View Article : Google Scholar : PubMed/NCBI
18	Garção P, Oliveira CR and Agostinho P: Comparative study of microglia activation induced by amyloid-beta and prion peptides: Role in neurodegeneration. J Neurosci Res. 84:182–193. 2006. View Article : Google Scholar : PubMed/NCBI
19	Song PJ, Barc C, Arlicot N, Guilloteau D, Bernard S, Sarradin P, Chalon S, Garreau L, Kung HF, Lantier F and Vergote J: Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Mol Imaging Biol. 12:576–582. 2010. View Article : Google Scholar : PubMed/NCBI
20	Thellung S, Florio T, Corsaro A, Arena S, Merlino M, Salmona M, Tagliavini F, Bugiani O, Forloni G and Schettini G: Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106–126. Int J Dev Neurosci. 18:481–492. 2000. View Article : Google Scholar : PubMed/NCBI
21	Veerhuis R, Hoozemans JJ, Janssen I, Boshuizen RS, Langeveld JP and Eikelenboom P: Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: No intermediary role for prostaglandin E2. Brain Res. 925:195–203. 2002. View Article : Google Scholar : PubMed/NCBI
22	Miyazono M, Iwaki T, Kitamoto T, Kaneko Y, Doh-ura K and Tateishi J: A comparative immunohistochemical study of Kuru and senile plaques with a special reference to glial reactions at various stages of amyloid plaque formation. Am J Pathol. 139:589–598. 1991.PubMed/NCBI
23	Fonseca AC, Romão L, Amaral RF, Assad Kahn S, Lobo D, Martins S, Marcondes de Souza J, Moura-Neto V and Lima FR: Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells. Neuroscience. 200:130–141. 2012. View Article : Google Scholar : PubMed/NCBI
24	Walsh DT, Perry VH and Minghetti L: Cyclooxygenase-2 is highly expressed in microglial-like cells in a murine model of prion disease. Glia. 29:392–396. 2000. View Article : Google Scholar : PubMed/NCBI
25	Adori C, Kovács GG, Low P, Molnár K, Gorbea C, Fellinger E, Budka H, Mayer RJ and László L: The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: Intracellular redistribution of components correlates with neuronal vulnerability. Neurobiol Dis. 19:427–435. 2005. View Article : Google Scholar : PubMed/NCBI
26	Lu ZY, Baker CA and Manuelidis L: New molecular markers of early and progressive CJD brain infection. J Cell Biochem. 93:644–652. 2004. View Article : Google Scholar : PubMed/NCBI
27	Ledoux AC and Perkins ND: NF-κB and the cell cycle. Biochem Soc Trans. 42:76–81. 2014. View Article : Google Scholar : PubMed/NCBI